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T he neutrophil-to-lymphocyte ratio (NLR) has been shown to predict outcomes in oncology 
patients,  including lung,  ovary,  and breast cancer 
patients [1].  The preoperative NLR is reportedly a prog-
nostic factor in patients undergoing colorectal cancer 
resection [2],  and the NLR measured upon admission 
to an intensive care unit (ICU) was found to be associ-
ated with both short- and long-term mortality in criti-
cally ill adult patients [1].  Compared to other inflam-
mation-based prognostic scores,  the NLR and the 
platelet-to-lymphocyte ratio (PLR) have been reported 
to have superior predictive power for mortality in 
patients with a gastrointestinal perforation [3].  The 
NLR can also predict bacteremia better than other 
infection markers [4],  with an NLR > 7 reported to be 
an independent marker of mortality in patients with 
bacteremia [5].
No study has reported an association between the 
mortality in patients with pneumonia and inflamma-
tion-based prognostic scores,  including the Glasgow 
Prognostic Score (GPS; based on the serum levels of 
C-reactive protein [CRP] and albumin),  the NLR,  the 
PLR,  the Prognostic Nutritional Index (PNI; based on 
albumin and lymphocyte counts),  and the Prognostic 
Index (PI; based on serum CRP and white blood cell 
counts),  which are also significant prognostic markers 
in several types of cancer [6].  Here,  we hypothesized 
that the NLR measured at the time of admission to an 
ICU may better predict in-hospital mortality in patients 
with pneumonia compared to other inflamma-
tion-based prognostic scores.
The study protocol was approved by the Ethics 
Committee of Osaka Medical College (Osaka,  Japan,  
#2207).  We retrospectively analyzed the cases of 33 
patients diagnosed with pneumonia based on symptoms 
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A neutrophil-to-lymphocyte ratio (NLR) > 7 is reportedly an independent marker of mortality in patients with 
bacteremia.  However,  no studies have shown an association between inflammation-based prognostic scores 
(including the Glasgow Prognostic Score,  the NLR,  the platelet-to-lymphocyte ratio,  the Prognostic 
Nutritional Index,  and the Prognostic Index) and mortality in patients with pneumonia.  We retrospectively 
examined the cases of 33 patients diagnosed with pneumonia who were treated in the ICU of Osaka Medical 
College Hospital between January 2014 and June 2016.  A multivariate analysis revealed that the NLR was a sig-
nificant predictor of mortality in these pneumonia patients.
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and examination (e.g.,  cough,  sputum,  fever,  infiltrates 
on chest radiographs,  positive sputum culture) who 
were treated and intubated in the ICU of Osaka Medical 
College Hospital between January 2014 and June 2016.  
The main outcome measure was in-hospital mortality.  
The indication criteria for tracheal intubation were (1) 
respiratory distress with FiO2 ≥ 0.5 and SaO2 < 90%,  
and/or (2) pCO2 ≥ 50 with a decreased respiratory rate 
or respiratory distress.  We excluded the patients aged 
≤ 18 years,  those who had any immunosuppressive dis-
ease (e.g.,  HIV),  and those undergoing immunosup-
pressive therapy (e.g.,  chemotherapy,  chronic steroid 
use,  autoimmune disease treatment) within 1 month of 
the study.
We collected the patients’ demographic and clinical 
data from their medical records (Table 1).  Continuous 
variables are expressed as the median (interquartile 
range),  and categorical variables are expressed as 
counts (percentage).  Patient characteristics were com-
pared between the survivors (n = 22) and non-survivors 
(n = 11) using the Mann-Whitney U-test.  Significant 
variables identified in a univariate analysis were subse-
quently assessed with a multivariate logistic regression 
analysis.  Receiver operating characteristics (ROC) 
curves were generated for variables which were signifi-
cant in the multivariate analysis.
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Table 1 Demographics of  the study population
Variable
All patients Univariate analysis
Non-survivors (n＝11) Survivors (n＝22) P-value
Age,  years 74 (65.5-79.5) 77 (73.3-79) 0.57
Male 10 (91) 13 (59) 0.108
Female 1 (9) 9 (41)
CAD 1 (9) 8 (36.4) 0.68
Diabetes 1 (9) 6 (27.3) 1.000
Hypertension 3 (27.3) 10 (45.5) 0.702
Renal disease 5 (45.5) 4 (18.2) 0.121
In-ICU LOS 12 (4-15.5) 9 (4-15) 0.924
A-DROP score 3 (2-4.5) 3 (2-4) 0.660
Albumin (g/l) 22 (17.5-25) 24 (21-27.8) 0.235
CRP (mg/l) 13 (5.6-17.6) 10.8 (3.4-19.8) 0.818
WBC (×109/l) 8.8 (5.9-13.1) 9.7 (7.1-11.8) 0.878
Neutrophil count (×109/l) 7.8 (5-11.7) 8.5 (5.3-10.1) 0.64
Lymphocyte count (×109/l) 0.36 (0.21-0.49) 0.78 (0.31-0.97) 0.027
Plt count (×104/㎜3) 6 (3-21) 17.6 (11.5-26.5) 0.067
CAD,  coronary artery disease; ICU,  intensive care unit; LOS,  length of stay; CRP,  C-reactive protein; WBC,  white blood cell; Plt,  
platele.
Table 2 Inﬂammation-based prognostic scores
Variables
All patients Univariate analysis
Non-survivors (n＝11) Survivors (n＝22) P-value
SOFA score at ICU admission 8 (6.5-10) 5.5 (4-7) 0.03
MPMⅡ 65.5 (46.9-72.9) 55.4 (27.9-64.5) 0.35
GPS (0/1/2) (0/11/0) (1/21/0) 0.479
NLR 21.8 (17.5-44.9) 9.4 (7.2-19) 0.022
PLR 401.5 (95.9-534.7) 302.1 (163.5-517.5) 0.73
PI (0/1/2) (0/6/5) (0/14/8) 0.69
PNI 24.5 (18.7-26.8) 27.3 (22.1-32) 0.056
SOFA,  sequential organ failure assessment; ICU,  intensive care unit; MPMⅡ,  Mortality Probability ModelⅡ; GPS,  Glasgow prognostic 
score; NLR,  neutrophil to lymphocyte ratio; PLR,  platelet to lymphocyte ratio; PI,  prognostic index; PNI,  prognostic nutritional index.
The baseline characteristics of the patients are sum-
marized in Table 1.  The univariate analysis revealed 
that the SOFA score (sequential organ failure assess-
ment) at ICU admission,  the lymphocyte count,  and 
the NLR were significant predictors of mortality (Tables 
1 and 2).  The multivariate analysis of these significant 
variables revealed the NLR (odds ratio: 1.074,  95% 
confidence interval [CI]: 1.001-1.152,  p = 0.047) as an 
independent significant predictor of mortality (Table 3).
An ROC curve was generated for the NLR,  and the 
cut-off value for mortality was 15.6 (sensitivity,  81.8%;  
specificity,  68.2%; positive predictive value,  56.3%;  
negative predictive value,  88.2%; positive likelihood 
ratio,  2.57; negative likelihood ratio,  0.27; area under 
the curve,  0.75; 95%CI,  0.56-0.94; p = 0.011).  The 
scatter diagram showed no correlation between the NLR 
and SOFA score at ICU admission in the non-survivors 
(Fig. 1).
Our results demonstrated that the NLR was superior 
to other inflammation-based prognostic scores in pre-
dicting the mortality of patients with pneumonia.  
Another study reported that lymphopenia was observed 
in 89 of 90 oncological ICU patients following major 
surgery,  sepsis,  and septic shock,  and moreover,  there 
was a correlation between the severity of the clinical 
course and the extent of lymphopenia [7].  In the pres-
ent study,  lymphopenia was observed significantly 
more often among the non-survivors compared to the 
survivors.  Previous studies did not assess the associa-
tions between inflammation-based prognostic scores 
(including the GPS,  NLR,  PLR,  PNI,  and PI) and 
mortality.  Our results are informative in this respect.
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Table 3 Predictors of mortality by multivariate logistic regression 
analysis
Predictor Odds ratio 95%CI P-value
SOFA score 1.418 0.956-2.104 0.083
NLR 1.074 1.001-1.152 0.047
Lymphocyte count 0.998 0.994-1.001 0.213
SOFA,  sequential organ failure assessment; NLR,  neutrophil to 
lymphocyte ratio.
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Fig. 1 No correlation was observed between the NLR and SOFA 
score at ICU admission in the non-survivors.
